Catherine Sylvain
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Peptidase Inhibition and Analysis
Papers in
-
- Ubiquitin and proteasome pathways 4
- Chemical Synthesis and Analysis 2
-
- Asymmetric Synthesis and Catalysis 2
- Synthetic Organic Chemistry Methods 2
- Chemical Synthesis and Reactions 2
- Co-authors
- Monette Aujay (4 shared papers)Francesco Parlati (4 shared papers)Érika Suzuki (2 shared papers)Mark K. Bennett (4 shared papers)Marcus Groettrup (1 shared paper)Susan D. Demo (3 shared papers)Christoph Lauer (1 shared paper)Jamie Shields (1 shared paper)
- Journals
- Tetrahedron Letters (3 papers)Blood (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Nature Medicine (1 paper)Synthesis (1 paper)
- Partner nations
- FranceUnited StatesNorway
In The Last Decade
Catherine Sylvain
11 papers receiving 958 citations
Peers
Comparison fields: 5 of 82
- Hematology 165
- Oncology 308
- Molecular Biology 680
- Immunology 172
- Organic Chemistry 221
Countries citing papers authored by Catherine Sylvain
This map shows the geographic impact of Catherine Sylvain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Sylvain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Sylvain more than expected).
Fields of papers citing papers by Catherine Sylvain
This network shows the impact of papers produced by Catherine Sylvain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Sylvain. The network helps show where Catherine Sylvain may publish in the future.
Co-authors
The 25 scholars most cited alongside Catherine Sylvain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 494 | |
| 2 | 2009 | 270 | |
| 3 | 2004 | 152 | |
| 4 | 1997 | 30 | |
| 5 | 1999 | 15 | |
| 6 | 1998 | 8 | |
| 7 | 2015 | 5 | |
| 8 | 2015 | 3 | |
| 9 | 1998 | 1 | |
| 10 | 2007 | 1 | |
| 11 | 2006 | 1 |
About Catherine Sylvain
Catherine Sylvain is a scholar working on Molecular Biology, Organic Chemistry, Immunology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 11 papers that have together received 980 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (4 papers), Asymmetric Synthesis and Catalysis (2 papers), Mast cells and histamine (2 papers), Synthetic Organic Chemistry Methods (2 papers), Chemical Synthesis and Reactions (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Chemical Synthesis and Analysis (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Hematology (165 citations), Oncology (308 citations), Molecular Biology (680 citations), Immunology (172 citations) and Organic Chemistry (221 citations). Catherine Sylvain has collaborated with scholars based in France, United States and Norway. Frequent co-authors include Monette Aujay, Francesco Parlati, Érika Suzuki, Mark K. Bennett, Marcus Groettrup, Susan D. Demo, Christoph Lauer, Jamie Shields, Jing Jiang and Peter J. Shwonek. Their work appears in journals such as Tetrahedron Letters, Blood, Bioorganic & Medicinal Chemistry Letters, Nature Medicine and Synthesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.